Ly-49I Antibodies

Santa Cruz Biotechnology offers a broad range of Ly-49I monoclonal antibodies for immunology and cell biology research. Ly-49I monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Ly-49I is a member of the Ly-49 family of receptors, which regulate natural killer (NK) cell activity. The Ly-49I receptor plays a significant role in the immune response by recognizing specific ligands on target cells, thereby influencing NK cell-mediated cytotoxicity and cytokine production. Understanding Ly-49I function is essential for elucidating mechanisms of immune regulation and potential therapeutic interventions in cancer and infectious diseases. Researchers can explore NK cell biology through precise detection and analysis of Ly-49I expression patterns. Investigating Ly-49I interactions provides valuable information about immune system regulation and NK cell development. Current studies focusing on Ly-49I contribute to the development of immunotherapy strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of immune system complexity and potential therapeutic applications.